Alpha Wave Global Takes 5.0% Stake in Alto Neuroscience

Ticker: ANRO · Form: SC 13G · Filed: 2024-02-09T00:00:00.000Z

Sentiment: bullish

Topics: institutional-ownership, insider-buy, pharmaceuticals

TL;DR

**Alpha Wave Global just bought 5% of Alto Neuroscience, signaling a bullish institutional bet.**

AI Summary

Alpha Wave Global, LP, a Delaware-based investment firm, has reported a significant stake in Alto Neuroscience, Inc. (NASDAQ: ALTO), a pharmaceutical preparations company. As of February 6, 2024, Alpha Wave Global beneficially owns 2,000,000 shares of Alto Neuroscience's common stock, representing 5.0% of the company's outstanding shares. This matters to investors because a major institutional investor taking a 5% stake can signal confidence in the company's future prospects, potentially attracting more investor interest and influencing stock performance.

Why It Matters

This filing indicates a notable institutional investor, Alpha Wave Global, has acquired a significant position in Alto Neuroscience, which could be interpreted as a vote of confidence in the company's potential.

Risk Assessment

Risk Level: low — This filing indicates a new institutional investor, which generally adds stability and confidence, reducing immediate risk.

Analyst Insight

A smart investor would research Alpha Wave Global's investment thesis and Alto Neuroscience's fundamentals to understand the potential drivers behind this institutional investment, considering it a positive signal.

Key Numbers

2,000,000 — Shares Beneficially Owned (The total number of Alto Neuroscience shares owned by Alpha Wave Global, LP.)
5.0% — Percentage of Class (The percentage of Alto Neuroscience's common stock owned by Alpha Wave Global, LP.)
$0.0001 — Par Value per Share (The stated par value of Alto Neuroscience's common stock.)
February 6, 2024 — Date of Event (The date when the event requiring this filing occurred.)

Key Players & Entities

Alpha Wave Global, LP (company) — the reporting person and institutional investor
Alto Neuroscience, Inc. (company) — the subject company whose shares were acquired
Delaware (company) — place of organization for Alpha Wave Global, LP
03 Life Sciences (company) — organization name associated with Alto Neuroscience, Inc.

Forward-Looking Statements

Alto Neuroscience's stock price may see increased investor interest due to Alpha Wave Global's significant stake. (Alto Neuroscience, Inc.) — medium confidence, target: Q2 2024

FAQ

Who is the reporting person in this SC 13G filing?

The reporting person is Alpha Wave Global, LP, as stated in Item 1 of the filing and the 'FILED BY' section.

What is the name of the issuer whose securities are being reported?

The issuer is Alto Neuroscience, Inc., as identified in the 'SUBJECT COMPANY' section and the title of the filing.

What percentage of Alto Neuroscience, Inc.'s common stock does Alpha Wave Global, LP beneficially own?

Alpha Wave Global, LP beneficially owns 5.0% of Alto Neuroscience, Inc.'s common stock, as indicated in the filing's summary and cover page.

What was the date of the event that triggered this SC 13G filing?

The date of the event which required the filing of this statement was February 6, 2024, as specified on the cover page of the filing.

What is the CUSIP number for Alto Neuroscience, Inc.'s common stock?

The CUSIP number for Alto Neuroscience, Inc.'s common stock is 02157Q109, as listed on the cover page of the filing.

From the Filing

0000902664-24-001347.txt : 20240209 0000902664-24-001347.hdr.sgml : 20240209 20240209093134 ACCESSION NUMBER: 0000902664-24-001347 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Alto Neuroscience, Inc. CENTRAL INDEX KEY: 0001999480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834210124 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-94343 FILM NUMBER: 24611942 BUSINESS ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 773-255-5012 MAIL ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Alpha Wave Global, LP CENTRAL INDEX KEY: 0001558858 ORGANIZATION NAME: IRS NUMBER: 300694893 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 2128039080 MAIL ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Falcon Edge Capital, LP DATE OF NAME CHANGE: 20190513 FORMER COMPANY: FORMER CONFORMED NAME: Falcon Edge Capital LP DATE OF NAME CHANGE: 20120924 SC 13G 1 p24-0728sc13g.htm ALTO NEUROSCIENCE, INC. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Alto Neuroscience, Inc. (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) 02157Q109 (CUSIP Number) February 6, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Rule 13d-1(b) ý Rule 13d-1(c) ¨ Rule 13d-1(d) (Page 1 of 9 Pages) ______________________________ *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (" Act ") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 02157Q109 13G Page 2 of 9 Pages 1 NAME OF REPORTING PERSON Alpha Wave Global, LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 3,707,757	 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 3,707,757 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,707,757 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 13.8% 12 TYPE OF REPORTING PERSON IA CUSIP No. 02157Q109 13G Page 3 of 9 Pages 1 NAME OF REPORTING PERSON Alpha Wave Ventures GP, Ltd 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 3,707,757 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 3,707,757 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,707,757 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 13.8% 12 TYPE OF REPORTI